GSTM2 and glioblastoma: Then, FN1, APOE, RPL7A and GSTM2 were identified as the 4 key OS-predicting GDRGs, and a clinically applicable prognostic nomogram using these 4 GDRGs and other clinicopathological variables was successfully developed for GBM patients.